Cargando…
Efficacy, safety and mechanism of Honghua Xiaoyao Pill in the treatment of peri-menopausal syndrome: A study protocol for a randomized controlled trial
Background: Peri-menopausal syndrome (PMPS) has a high incidence rate and seriously affects the physical and mental health of women. Honghua Xiaoyao Pill (HHXYP) is a Chinese patent medicine, which has been reported to be used to treat PMPS. However, there is still a lack of randomized clinical tria...
Autores principales: | Wu, Xiao, Zhou, Lishan, Dong, Haoxu, Tian, Man, Liu, Shiqin, Xu, Xiaohu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773080/ https://www.ncbi.nlm.nih.gov/pubmed/36569324 http://dx.doi.org/10.3389/fphar.2022.1001228 |
Ejemplares similares
-
Xiaoyao Pills Prevent Lipopolysaccharide-Induced Depression by Inhibiting Inflammation and Protecting Nerves
por: Shi, Boyu, et al.
Publicado: (2019) -
Efficacy and safety of Xiaoyao pills for mild to moderate depression: study protocol for a randomized controlled trial
por: Xue, Zhe, et al.
Publicado: (2022) -
Safety and efficacy of Xiaoyao-san for the treatment of functional dyspepsia: a systematic review and meta-analysis of randomized controlled trials
por: Ha, Na-Yeon, et al.
Publicado: (2023) -
Danshen-Honghua Ameliorates Stress-Induced Menopausal Depression in Rats
por: Gu, Simeng, et al.
Publicado: (2018) -
Comparative efficacy of Honghua class injections for treating acute ischemic stroke: A Bayesian network meta-analysis of randomized controlled trials
por: Li, Lan, et al.
Publicado: (2022)